The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

I am an 84-year-old male in fairly good health for my age. I take 8-10 pills a day, including two over-the-counter ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.